Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.
about
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.A Low Lymphocyte-to-Monocyte Ratio Predicts Unfavorable Prognosis in Pathological T3N0 Rectal Cancer Patients Following Total Mesorectal Excision.Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort studyDistinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Ovarian CancerThe Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinomaPrognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.Associations between elevated pre-treatment serum cytokines and peripheral blood cellular markers of immunosuppression in patients with lymphoma.Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis.Identifying pretreatment baseline factors predictive of distant metastasis in patients with nasopharyngeal carcinoma after radiotherapy.The Prediction Value of the Systemic Inflammation Score for Oral Cavity Squamous Cell Carcinoma.
P2860
Q30235263-364A0795-BDF0-44F6-ADA5-C9A2EE2D6194Q35739526-09CA22C3-40C8-4AE9-A287-9CAE250F526BQ35998990-07E7E3A9-3C6F-479B-924F-F354E534E054Q36540944-5CE771A6-C556-4534-95EF-1CAD0BE9FB9EQ36563905-B2B086B2-B878-45E5-9CB2-176718A764A3Q36764919-8C0453F6-43CF-4E64-924A-5993F12B4796Q37064572-3FD8AC8C-C858-44B4-BDB9-EB6CF18E3065Q37362567-B98FAF9C-C83F-44B5-AA81-4BCA23296FBDQ38850729-7C6A0012-3062-46A6-84A9-0B9F2EEECC88Q38901921-41A29289-A7DF-480E-B325-122C8BF12E1FQ41093379-9AE82217-4B59-4A90-BA58-298F440D8FFDQ41554887-AD050368-C33E-4823-A89F-CCCBC58B54AAQ42267225-CCD95796-8A0D-44A4-B37A-5C1715575488Q50039906-CCABA46D-24C0-4821-9B68-0117C92F0FF2
P2860
Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@en
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@nl
type
label
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@en
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@nl
prefLabel
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@en
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@nl
P2093
P2860
P1433
P1476
Increased lymphocyte to monocy ...... cinoma receiving chemotherapy.
@en
P2093
Dong-Ying Liu
Gui-Nan Lin
Jian-Jun Xiao
Jie-Wen Peng
Xiao-Qin Chen
Yue-Qiong Chen
P2860
P2888
P304
10849-10854
P356
10.1007/S13277-014-2362-6
P577
2014-08-01T00:00:00Z